REDLAMP 11: Does a Family History of Lymphoma Increase My Risk?

Great strides in the understanding of familial predisposition to common forms of lymphoma including non-Hodgkin lymphoma, Hodgkin lymphoma, and chronic lymphocytic leukemia have been made in the past decade. Many lymphoma patients wonder if their family faces an increased risk. In this video Dr. Peter Martin explains the results from a recent study published in Blood, which sought to quantify these risks, and give a better understanding of how a family history of lymphoma increases the risk for other family members.

Previous #REDLAMP entries can be viewed on our Youtube channel.

We encourage you to follow the Lymphoma Program on Twitter, Youtube, and Facebook where we will highlight new videos are about research publications as they are released. We also welcome your feedback, suggestions and questions about this project. If you have other questions about our lymphoma program or clinical trials or would like to see one of our lymphoma specialists, please contact us at 212-746-2919.

#EdForumChat Tweet Chat Recap with Dr. John Leonard

Over the weekend Dr. John Leonard answered questions via Twitter from the Lymphoma Research Foundation under the hashtag #EdForumChat about lymphoma, lymphoma treatment options, and lymphoma research.

In case you were unable to participate an edited transcript of the Tweet Chat is available.

Dr. Leonard can be followed on Twitter @JohnPLeonardMD.

“Is the open mouth mightier than the needle?” Dr. Peter Martin on Ibrutinib for MCL Patients

In the latest issue of Blood, Dr. Peter Martin writes about the latest use of ibrutinib for patients with mantle cell lymphoma.